Skip to main content

CCXI Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

ChemoCentryx Inc. News

5 Top Stock Gainers for Friday: ChemoCentryx, Plug Power, Quidel

ChemoCentryx, Plug Power, Quidel, Avis Budget and Murphy Oil are five top stock gainers for Friday.

ChemoCentryx Stock Leaps as FDA Approves Vasculitis Drug

The FDA on Friday approved ChemoCentryx's drug candidate, Tavneos, to treat a rare, fatal autoimmune disease. The stock is higher.

ChemoCentryx Rises on Update to FDA Vasculitis-Drug Filing

ChemoCentryx jumps after filing with the FDA, and amending, a new-drug application for a vasculitis treatment.

ChemoCentryx Nosedives on Split FDA Panel Decision

ChemoCentryx falls on the FDA committee's lukewarm support and analysts' downgrades.

Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years

Small-cap stocks have finally jumped back to life on prospects for a strong U.S. economy this year. What trade war?

Breaking News

Morgan Stanley Stock Leads Gains As Banks Boost Dividends After Fed Stress Tests

Morgan Stanley, Wells Fargo, Bank of America and Goldman Sachs will lift their quarterly dividend, while JPMorgan will hold its steady following last week's Fed stress tests.

Nike Stock Slides As As Margin Pressures, China Worries Offset Q4 Earnings Beat

"We think we're well positioned for growth in fiscal year 2023 ... having said that, we did take a cautious approach to Greater China," said CFO Matthew Friend.

Playtika Stock Slumps After Joffre Capital Takes 25.7% Stake Online Casino Gaming Group

Axios reported late Monday that tech buyout group Joffre Capital is seeking a majority stake in the online casino video game group.

Walgreens Stock Slides As Group Scraps Plan to Sell UK-based Boots

"As a result of market instability ... no third party has been able to make an offer that adequately reflects the high potential value of Boots," Walgreens said.